Keyphrases
Cancer Cells
100%
Cell Surface Markers
100%
CD133
100%
Stem Cells
100%
C-X-C Chemokine Receptor Type 4 (CXCR4)
100%
Primary Endometrial Cancer
100%
Cancer Stem Cells
50%
Endometrial Cancer
50%
CD24
33%
Surface Markers
33%
Stemness Genes
33%
Endometrial Cancer Cells
33%
Tissue Sampling
16%
Flow Cytometry
16%
Poor Prognosis
16%
Cancer Patients
16%
Cultured Cells
16%
Histological Analysis
16%
Surgical Procedures
16%
Quantitative PCR
16%
Nude Mice
16%
SSEA-4
16%
Cluster of Differentiation 44 (CD44)
16%
High-level Expression
16%
Predictive Marker
16%
Chemokines
16%
Actin
16%
Molecular Targets
16%
Anticancer Drugs
16%
C-Myc
16%
Nestin
16%
ABCG2
16%
Malignant Tumor
16%
Sex-determining Region Y-box 2 (SOX2)
16%
Stem Cell Markers
16%
SSEA-3
16%
Nanog
16%
Cluster of Differentiation 47 (CD47)
16%
Female Reproductive System
16%
BMI1
16%
CD29
16%
Clonogenic
16%
Cytokeratin 18
16%
Medicine and Dentistry
Cancer Cell
100%
Cell Surface Marker
100%
Uterine Cancer
100%
Cancer Stem Cell
37%
Body Mass Index
12%
Surgical Technique
12%
Cell Marker
12%
Stem Cell
12%
Flow Cytometry
12%
Malignant Neoplasm
12%
Chemokine
12%
Histopathology
12%
Actin
12%
Anticarcinogen
12%
Predictive Marker
12%
Reverse Transcription Polymerase Chain Reaction
12%
Genetic Transfection
12%
Reproductive System
12%
Breast Cancer Resistance Protein
12%
Oncogene C Myc
12%
Nestin
12%
Messenger RNA
12%
Immunology and Microbiology
Cell Surface Marker
100%
Cancer Cell
100%
CXCR4
100%
Cancer Stem Cell
50%
CD44
16%
Cell Marker
16%
Stem Cell
16%
Actin
16%
Genetic Transfection
16%
Chemokine
16%
Oncogene C Myc
16%
Reverse Transcription Polymerase Chain Reaction
16%
Nude Mouse
16%
CD29
16%
CD47
16%
ABCG2
16%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Cell Surface Marker
100%
Endometrium Cancer
100%
Flow Cytometry
12%
Molecular Target
12%
Nude Mouse
12%
Cell Marker
12%
Anticarcinogen
12%
Chemokine
12%
Actin
12%
ABCG2
12%
Nestin
12%
Messenger RNA
12%